NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$49.57 -0.22 (-0.44 %)
(As of 05/23/2019 08:38 AM ET)
Previous Close$49.79
Today's Range$49.05 - $49.91
52-Week Range$36.28 - $80.66
Volume897,026 shs
Average Volume1.47 million shs
Market Capitalization$6.74 billion
P/E Ratio10.89
Dividend Yield1.53%
Beta1.29
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. It operates in Europe, Australia, Israel, Mexico, the United States, Canada, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.73 billion
Cash Flow$7.6497 per share
Book Value$41.92 per share

Profitability

Net Income$131 million

Miscellaneous

Employees10,600
Market Cap$6.74 billion
Next Earnings Date8/8/2019 (Estimated)
OptionableOptionable

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Friday, April 26th. Shareholders of record on Friday, May 31st will be given a dividend of $0.21 per share on Tuesday, June 18th. This represents a $0.84 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date is Thursday, May 30th. This is a boost from Perrigo's previous quarterly dividend of $0.19. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo Company PLC (NYSE:PRGO) released its earnings results on Wednesday, May, 8th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.13. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.15 billion. Perrigo had a return on equity of 10.40% and a net margin of 2.43%. During the same period last year, the firm posted $1.26 EPS. View Perrigo's Earnings History.

When is Perrigo's next earnings date?

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2019 earnings guidance on Thursday, May, 9th. The company provided earnings per share (EPS) guidance of $3.65-3.95 for the period, compared to the Thomson Reuters consensus estimate of $4.20. The company issued revenue guidance of $4.6-4.7 billion, compared to the consensus revenue estimate of $4.71 billion.

What price target have analysts set for PRGO?

14 equities research analysts have issued twelve-month price targets for Perrigo's shares. Their forecasts range from $47.00 to $110.00. On average, they anticipate Perrigo's share price to reach $73.00 in the next twelve months. This suggests a possible upside of 47.3% from the stock's current price. View Analyst Price Targets for Perrigo.

What is the consensus analysts' recommendation for Perrigo?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Has Perrigo been receiving favorable news coverage?

Media stories about PRGO stock have been trending positive this week, InfoTrie reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 2.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the next few days.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Celgene (CELG), Mylan (MYL), Twitter (TWTR), Allergan (AGN), Amgen (AMGN), Netflix (NFLX), Starbucks (SBUX) and General Electric (GE).

Who are Perrigo's key executives?

Perrigo's management team includes the folowing people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 59)
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 59)
  • Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 63)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 57)
  • Mr. Ronald L. Winowiecki, Advisory (Age 53)

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.23%), FMR LLC (4.73%), Dimensional Fund Advisors LP (1.79%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.59%), Parnassus Investments CA (1.44%) and Geode Capital Management LLC (1.32%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Clal Insurance Enterprises Holdings Ltd, JPMorgan Chase & Co., Sasco Capital Inc. CT, New York State Common Retirement Fund, Manning & Napier Group LLC, State of Wisconsin Investment Board and SEI Investments Co. View Insider Buying and Selling for Perrigo.

Which institutional investors are buying Perrigo stock?

PRGO stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Parnassus Investments CA, First Trust Advisors LP, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, LSV Asset Management, Parametric Portfolio Associates LLC, Wellington Management Group LLP and Federated Investors Inc. PA. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $49.57.

How big of a company is Perrigo?

Perrigo has a market capitalization of $6.74 billion and generates $4.73 billion in revenue each year. The company earns $131 million in net income (profit) each year or $4.55 on an earnings per share basis. Perrigo employs 10,600 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is http://www.perrigo.com/.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


MarketBeat Community Rating for Perrigo (NYSE PRGO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  673 (Vote Outperform)
Underperform Votes:  639 (Vote Underperform)
Total Votes:  1,312
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel